Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure–associated autoantibodies
- 28 September 2000
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (4) , 1280-1287
- https://doi.org/10.1016/s0735-1097(00)00881-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Autoantibodies Activating Human β 1 -Adrenergic Receptors Are Associated With Reduced Cardiac Function in Chronic Heart FailureCirculation, 1999
- Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cellsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
- Inverse agonism and the regulation of receptor numberTrends in Pharmacological Sciences, 1997
- Anti‐peptide antibodies sensitive to the ‘active’ state of the β2‐adrenergic receptorFEBS Letters, 1996
- Probing human β1- and β2-adrenoceptors with domain-specific fusion protein antibodiesEuropean Journal of Pharmacology, 1996
- Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.Circulation, 1994
- Autoantibodies against the -adrenergic receptor in human myocarditis and dilated cardiomyopathy: -adrenergic agonism without desensitizationEuropean Heart Journal, 1991
- Role of extracellular disulfide-bonded cysteines in the ligand binding function of the .beta.2-adrenergic receptorBiochemistry, 1990
- Anti-receptor antibodies in human diseaseJournal of Allergy and Clinical Immunology, 1984
- Antibodies to major histocompatibility antigens produced by hybrid cell linesNature, 1977